Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Preventing Early Renal Loss in Diabetes (PERL) Study: A Randomized Double-Blinded Trial of Allopurinol-Rationale, Design, and Baseline Data.

Afkarian M, Polsky S, Parsa A, Aronson R, Caramori ML, Cherney DZ, Crandall JP, de Boer IH, Elliott TG, Galecki AT, Goldfine AB, Haw JS, Hirsch IB, Karger AB, Lingvay I, Maahs DM, McGill JB, Molitch ME, Perkins BA, Pop-Busui R, Pragnell M, Rosas SE, Rossing P, Senior P, Sigal RJ, Spino C, Tuttle KR, Umpierrez GE, Wallia A, Weinstock RS, Wu C, Mauer M, Doria A; PERL Study Group.

Diabetes Care. 2019 Aug;42(8):1454-1463. doi: 10.2337/dc19-0342. Epub 2019 Jun 11.

PMID:
31186299
2.

Urinary Renin in Patients and Mice With Diabetic Kidney Disease.

Tang J, Wysocki J, Ye M, Vallés PG, Rein J, Shirazi M, Bader M, Gomez RA, Sequeira-Lopez MS, Afkarian M, Batlle D.

Hypertension. 2019 Jul;74(1):83-94. doi: 10.1161/HYPERTENSIONAHA.119.12873. Epub 2019 May 13.

PMID:
31079532
3.

The NASA Twins Study: A multidimensional analysis of a year-long human spaceflight.

Garrett-Bakelman FE, Darshi M, Green SJ, Gur RC, Lin L, Macias BR, McKenna MJ, Meydan C, Mishra T, Nasrini J, Piening BD, Rizzardi LF, Sharma K, Siamwala JH, Taylor L, Vitaterna MH, Afkarian M, Afshinnekoo E, Ahadi S, Ambati A, Arya M, Bezdan D, Callahan CM, Chen S, Choi AMK, Chlipala GE, Contrepois K, Covington M, Crucian BE, De Vivo I, Dinges DF, Ebert DJ, Feinberg JI, Gandara JA, George KA, Goutsias J, Grills GS, Hargens AR, Heer M, Hillary RP, Hoofnagle AN, Hook VYH, Jenkinson G, Jiang P, Keshavarzian A, Laurie SS, Lee-McMullen B, Lumpkins SB, MacKay M, Maienschein-Cline MG, Melnick AM, Moore TM, Nakahira K, Patel HH, Pietrzyk R, Rao V, Saito R, Salins DN, Schilling JM, Sears DD, Sheridan CK, Stenger MB, Tryggvadottir R, Urban AE, Vaisar T, Van Espen B, Zhang J, Ziegler MG, Zwart SR, Charles JB, Kundrot CE, Scott GBI, Bailey SM, Basner M, Feinberg AP, Lee SMC, Mason CE, Mignot E, Rana BK, Smith SM, Snyder MP, Turek FW.

Science. 2019 Apr 12;364(6436). pii: eaau8650. doi: 10.1126/science.aau8650.

PMID:
30975860
4.

Erratum. Urine Complement Proteins and the Risk of Kidney Disease Progression and Mortality in Type 2 Diabetes. Diabetes Care 2018;41:2361-2369.

Vaisar T, Durbin-Johnson B, Whitlock K, Babenko I, Mehrotra R, Rocke DM, Afkarian M.

Diabetes Care. 2019 Jun;42(6):1155. doi: 10.2337/dc19-er06a. Epub 2019 Apr 1. No abstract available.

5.

The early natural history of albuminuria in young adults with youth-onset type 1 and type 2 diabetes.

Kahkoska AR, Isom S, Divers J, Mayer-Davis EJ, Dolan L, Shah AS, Afkarian M, Pettitt DJ, Lawrence JM, Marcovina S, Saydah SH, Dabelea D, Maahs DM, Mottl AK; SEARCH for Diabetes in Youth Study Group.

J Diabetes Complications. 2018 Dec;32(12):1160-1168. doi: 10.1016/j.jdiacomp.2018.09.018. Epub 2018 Oct 4.

PMID:
30316542
6.

Urine Complement Proteins and the Risk of Kidney Disease Progression and Mortality in Type 2 Diabetes.

Vaisar T, Durbin-Johnson B, Whitlock K, Babenko I, Mehrotra R, Rocke DM, Afkarian M.

Diabetes Care. 2018 Nov;41(11):2361-2369. doi: 10.2337/dc18-0699. Epub 2018 Aug 27. Erratum in: Diabetes Care. 2019 Jun;42(6):1155.

PMID:
30150236
7.

Metabolomics and Gene Expression Analysis Reveal Down-regulation of the Citric Acid (TCA) Cycle in Non-diabetic CKD Patients.

Hallan S, Afkarian M, Zelnick LR, Kestenbaum B, Sharma S, Saito R, Darshi M, Barding G, Raftery D, Ju W, Kretzler M, Sharma K, de Boer IH.

EBioMedicine. 2017 Dec;26:68-77. doi: 10.1016/j.ebiom.2017.10.027. Epub 2017 Oct 31.

8.

Identification, Confirmation, and Replication of Novel Urinary MicroRNA Biomarkers in Lupus Nephritis and Diabetic Nephropathy.

Cardenas-Gonzalez M, Srivastava A, Pavkovic M, Bijol V, Rennke HG, Stillman IE, Zhang X, Parikh S, Rovin BH, Afkarian M, de Boer IH, Himmelfarb J, Waikar SS, Vaidya VS.

Clin Chem. 2017 Sep;63(9):1515-1526. doi: 10.1373/clinchem.2017.274175. Epub 2017 Jun 30.

9.

Vitamin D and Albuminuria in Youth with and without Type 1 Diabetes.

Nandi-Munshi D, Afkarian M, Whitlock KB, Crandell JL, Bell RA, D'Agostino R, Saydah S, Mottl AK, Dabelea D, Black MH, Mayer-Davis EJ, Pihoker C.

Horm Res Paediatr. 2017;87(6):385-395. doi: 10.1159/000475711. Epub 2017 May 29.

10.

Urine RAS components in mice and people with type 1 diabetes and chronic kidney disease.

Wysocki J, Goodling A, Burgaya M, Whitlock K, Ruzinski J, Batlle D, Afkarian M.

Am J Physiol Renal Physiol. 2017 Aug 1;313(2):F487-F494. doi: 10.1152/ajprenal.00074.2017. Epub 2017 May 3.

11.

Absolute Rates of Heart Failure, Coronary Heart Disease, and Stroke in Chronic Kidney Disease: An Analysis of 3 Community-Based Cohort Studies.

Bansal N, Katz R, Robinson-Cohen C, Odden MC, Dalrymple L, Shlipak MG, Sarnak MJ, Siscovick DS, Zelnick L, Psaty BM, Kestenbaum B, Correa A, Afkarian M, Young B, de Boer IH.

JAMA Cardiol. 2017 Mar 1;2(3):314-318. doi: 10.1001/jamacardio.2016.4652.

12.

Immunity and inflammation in diabetic kidney disease: translating mechanisms to biomarkers and treatment targets.

Pichler R, Afkarian M, Dieter BP, Tuttle KR.

Am J Physiol Renal Physiol. 2017 Apr 1;312(4):F716-F731. doi: 10.1152/ajprenal.00314.2016. Epub 2016 Aug 24. Review.

13.

Clinical Manifestations of Kidney Disease Among US Adults With Diabetes, 1988-2014.

Afkarian M, Zelnick LR, Hall YN, Heagerty PJ, Tuttle K, Weiss NS, de Boer IH.

JAMA. 2016 Aug 9;316(6):602-10. doi: 10.1001/jama.2016.10924.

14.

Serum amyloid a and risk of death and end-stage renal disease in diabetic kidney disease.

Dieter BP, McPherson SM, Afkarian M, de Boer IH, Mehrotra R, Short R, Barbosa-Leiker C, Alicic RZ, Meek RL, Tuttle KR.

J Diabetes Complications. 2016 Nov - Dec;30(8):1467-1472. doi: 10.1016/j.jdiacomp.2016.07.018. Epub 2016 Jul 27.

15.

An Optimized Method for Protein Extraction from OCT-Embedded Human Kidney Tissue for Protein Quantification by LC-MS/MS Proteomics.

Vrana M, Goodling A, Afkarian M, Prasad B.

Drug Metab Dispos. 2016 Oct;44(10):1692-6. doi: 10.1124/dmd.116.071522. Epub 2016 Aug 1.

16.

Diabetes, Kidney Disease, and Cardiovascular Outcomes in the Jackson Heart Study.

Afkarian M, Katz R, Bansal N, Correa A, Kestenbaum B, Himmelfarb J, de Boer IH, Young B.

Clin J Am Soc Nephrol. 2016 Aug 8;11(8):1384-91. doi: 10.2215/CJN.13111215. Epub 2016 Jun 23.

17.

Markers of kidney disease and risk of subclinical and clinical heart failure in African Americans: the Jackson Heart Study.

Bansal N, Katz R, Himmelfarb J, Afkarian M, Kestenbaum B, de Boer IH, Young B.

Nephrol Dial Transplant. 2016 Dec;31(12):2057-2064. Epub 2016 Jun 2.

18.

Impaired Glucose and Insulin Homeostasis in Moderate-Severe CKD.

de Boer IH, Zelnick L, Afkarian M, Ayers E, Curtin L, Himmelfarb J, Ikizler TA, Kahn SE, Kestenbaum B, Utzschneider K.

J Am Soc Nephrol. 2016 Sep;27(9):2861-71. doi: 10.1681/ASN.2015070756. Epub 2016 Jan 28.

19.

The Surging Tide of Diabetes: Implications for Nephrology.

de Boer IH, Afkarian M, Tuttle KR.

Am J Kidney Dis. 2016 Mar;67(3):364-6. doi: 10.1053/j.ajkd.2015.12.002. Epub 2015 Dec 23. No abstract available.

20.

Urine matrix metalloproteinase-7 and risk of kidney disease progression and mortality in type 2 diabetes.

Afkarian M, Zelnick LR, Ruzinski J, Kestenbaum B, Himmelfarb J, de Boer IH, Mehrotra R.

J Diabetes Complications. 2015 Nov-Dec;29(8):1024-31. doi: 10.1016/j.jdiacomp.2015.08.024. Epub 2015 Sep 2.

21.

A Cluster of Proteins Implicated in Kidney Disease Is Increased in High-Density Lipoprotein Isolated from Hemodialysis Subjects.

Shao B, de Boer I, Tang C, Mayer PS, Zelnick L, Afkarian M, Heinecke JW, Himmelfarb J.

J Proteome Res. 2015 Jul 2;14(7):2792-806. doi: 10.1021/acs.jproteome.5b00060. Epub 2015 Jun 15.

22.

Renal outcomes in patients with type 1 diabetes and macroalbuminuria.

de Boer IH, Afkarian M, Rue TC, Cleary PA, Lachin JM, Molitch ME, Steffes MW, Sun W, Zinman B; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Research Group.

J Am Soc Nephrol. 2014 Oct;25(10):2342-50. doi: 10.1681/ASN.2013091004. Epub 2014 Jun 12.

23.

Urinary excretion of RAS, BMP, and WNT pathway components in diabetic kidney disease.

Afkarian M, Hirsch IB, Tuttle KR, Greenbaum C, Himmelfarb J, de Boer IH.

Physiol Rep. 2014 May 2;2(5):e12010. doi: 10.14814/phy2.12010. Print 2014.

24.

Diabetic kidney disease in children and adolescents.

Afkarian M.

Pediatr Nephrol. 2015 Jan;30(1):65-74; quiz 70-1. doi: 10.1007/s00467-014-2796-5. Epub 2014 Mar 19. Review.

25.

Albuminuria according to status of autoimmunity and insulin sensitivity among youth with type 1 and type 2 diabetes.

Mottl AK, Lauer A, Dabelea D, Maahs DM, D'Agostino RB Jr, Dolan LM, Gilliam LK, Lawrence JM, Rodriguez B, Marcovina SM, Imperatore G, Kanakatti Shankar R, Afkarian M, Reynolds K, Liese AD, Mauer M, Mayer-Davis EJ; SEARCH for Diabetes in Youth Study Group.

Diabetes Care. 2013 Nov;36(11):3633-8. doi: 10.2337/dc13-0568. Epub 2013 Jul 11.

26.

Kidney disease and increased mortality risk in type 2 diabetes.

Afkarian M, Sachs MC, Kestenbaum B, Hirsch IB, Tuttle KR, Himmelfarb J, de Boer IH.

J Am Soc Nephrol. 2013 Feb;24(2):302-8. doi: 10.1681/ASN.2012070718. Epub 2013 Jan 29.

27.

Optimizing a proteomics platform for urine biomarker discovery.

Afkarian M, Bhasin M, Dillon ST, Guerrero MC, Nelson RG, Knowler WC, Thadhani R, Libermann TA.

Mol Cell Proteomics. 2010 Oct;9(10):2195-204. doi: 10.1074/mcp.M110.000992. Epub 2010 May 28.

28.

Klotho variants and chronic hemodialysis mortality.

Friedman DJ, Afkarian M, Tamez H, Bhan I, Isakova T, Wolf M, Ankers E, Ye J, Tonelli M, Zoccali C, Kuro-o M, Moe O, Karumanchi SA, Thadhani R.

J Bone Miner Res. 2009 Nov;24(11):1847-55. doi: 10.1359/jbmr.090516.

29.

T-bet is a STAT1-induced regulator of IL-12R expression in naïve CD4+ T cells.

Afkarian M, Sedy JR, Yang J, Jacobson NG, Cereb N, Yang SY, Murphy TL, Murphy KM.

Nat Immunol. 2002 Jun;3(6):549-57. Epub 2002 May 13.

PMID:
12006974
30.
31.

Kinase suppressor of Ras (KSR) is a scaffold which facilitates mitogen-activated protein kinase activation in vivo.

Nguyen A, Burack WR, Stock JL, Kortum R, Chaika OV, Afkarian M, Muller WJ, Murphy KM, Morrison DK, Lewis RE, McNeish J, Shaw AS.

Mol Cell Biol. 2002 May;22(9):3035-45.

32.

Signaling and transcription in T helper development.

Murphy KM, Ouyang W, Farrar JD, Yang J, Ranganath S, Asnagli H, Afkarian M, Murphy TL.

Annu Rev Immunol. 2000;18:451-94. Review.

PMID:
10837066
33.

Supplemental Content

Loading ...
Support Center